0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query delveinsight ankylosing spondylitis bekhterevs disease global api manufacturers marketed phase.Your search for "" gave back 1533061 results.
The global Humira market size was valued at USD 17560 million in 2023 and is forecast to a readjusted size of USD 9840.6 million by 2030 with a CAGR...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Summary The Tumor Necrosis Factor (TNF) Inhibitor Drugs market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a...
Catalog:
HYR
March 2021
Price: USD 2,000.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Summary HeyReport estimates that the Tumor Necrosis Factor (TNF) Inhibitor Drugs market size will grow from xxx Million USD in 2020 to xxxx Million...
Catalog:
HYR
July 2021
Price: USD 2,000.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Humira market size was valued at US$ 16700 million in 2023. With growing demand in downstream market, the Humira is forecast to a...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
GIR
April 2023
Price: USD 3,480.00
The “Ankylosing Spondylitis Drug Industry Forecast” looks at past sales and reviews total world Ankylosing Spondylitis Drug sales in 2022, providing...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The “Ankylosing Spondylitis Treatment Drug Industry Forecast” looks at past sales and reviews total world Ankylosing Spondylitis Treatment Drug sales...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Highlights The global Ankylosing Spondylitis Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Market Analysis and Insights: Global Ankylosing Spondylitis Treatment Drug Market The global Ankylosing Spondylitis Treatment Drug market is...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Highlights The global Ankylosing Spondylitis Treatment Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Etanercept, sold under the brand name Enbrel among others, is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Enbrel is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Uveitis - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uveitis -...
Catalog:
Global Markets Direct
September 2020
Price: USD 2,000.00
